Tyvaso DPI is a Oral Inhalant in the Human Prescription Drug category. It is labeled and distributed by United Therapeutics Corporation. The primary component is Treprostinil.
Product ID | 66302-748_46c30322-3a4d-41f0-b7c1-1e4aba4831be |
NDC | 66302-748 |
Product Type | Human Prescription Drug |
Proprietary Name | Tyvaso DPI |
Generic Name | Treprostinil |
Dosage Form | Inhalant |
Route of Administration | ORAL |
Marketing Start Date | 2022-05-23 |
Marketing Category | NDA / |
Application Number | NDA214324 |
Labeler Name | United Therapeutics Corporation |
Substance Name | TREPROSTINIL |
Active Ingredient Strength | 48 ug/1 |
Pharm Classes | Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-05-23 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
66302-101 | Remodulin | treprostinil |
66302-102 | Remodulin | treprostinil |
0703-0666 | Treprostinil | Treprostinil |
0703-0676 | Treprostinil | Treprostinil |
0703-0686 | Treprostinil | Treprostinil |
0703-0696 | Treprostinil | Treprostinil |
0781-3420 | Treprostinil | treprostinil |
0781-3425 | Treprostinil | treprostinil |
0781-3427 | Treprostinil | treprostinil |
0781-3430 | Treprostinil | treprostinil |
42023-206 | Treprostinil | Treprostinil |
42023-207 | Treprostinil | Treprostinil |
42023-208 | Treprostinil | Treprostinil |
42023-209 | Treprostinil | Treprostinil |
62332-514 | Treprostinil | Treprostinil |
62332-515 | Treprostinil | Treprostinil |
62332-516 | Treprostinil | Treprostinil |
62332-517 | Treprostinil | Treprostinil |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TYVASO DPI 90370386 not registered Live/Pending |
United Therapeutics Corporation 2020-12-09 |